Case Name (Date)

Lomedico et al. v. American Behavioral Research Institute LLC, d/b/a Relaxium
22-cv-6097, S.D.N.Y.
(July 2022)


Product/Service

Relaxium


Allegations

Misleadingly marketing that the supplement is a “clinically proven” sleep aid when the only scientific study conducted on the product was inadequate and sponsored by Relaxium

Falsely advertising that the supplement was developed by a “sleep expert” when he has no experience or background in treating sleep disorders


Status

Settled



The Latest

Filters

Skull Smash

Ad Alert

Skull Smash

FDA sniffs out unapproved claims company’s smelling salts increase alertness, focus, and more.


Show More